Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ascendis Pharma A/SADR(ASND) | 5,218,000 | 4,980,000 | -238,000 | $813.28M | $859.55M | 15.05% | +$46.27M |
| United Therapeutics Corporation(UTHR) | 2,675,000 | 2,370,000 | -305,000 | $824.62M | $681.02M | 11.93% | -$143.60M |
| argenx SEADR(ARGX) | 1,235,177 | 1,175,000 | -60,177 | $731.06M | $647.68M | 11.34% | -$83.37M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 2,022,222 | 1,875,000 | -147,222 | $669.82M | $567.45M | 9.94% | -$102.37M |
| Krystal Biotech, Inc.(KRYS) | 2,731,000 | 2,660,000 | -71,000 | $492.40M | $365.64M | 6.40% | -$126.76M |
| Kymera Therapeutics, Inc.(KYMR) | 6,460,000 | 6,555,555 | +95,555 | $176.81M | $286.08M | 5.01% | +$109.27M |
| Apellis Pharmaceuticals Inc. COM | 12,222,222 | 12,222,222 | 0 | $267.30M | $211.57M | 3.71% | -$55.73M |
| Avidity Biosciences Inc | 7,625,000 | 7,050,000 | -575,000 | $225.09M | $200.22M | 3.51% | -$24.87M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 2,770,100 | 4,150,000 | +1,379,900 | $108.23M | $195.88M | 3.43% | +$87.65M |
| Akero Therapeutics Inc | 0 | 3,500,000 | +3,500,000 | $0 | $186.76M | 3.27% | +$186.76M |
| Soleno Therapeutics Inc | 2,525,000 | 2,050,000 | -475,000 | $180.41M | $171.75M | 3.01% | -$8.66M |
| Xenon Pharmaceuticals Inc.(XENE) | 5,741,666 | 5,400,000 | -341,666 | $192.63M | $169.02M | 2.96% | -$23.61M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 11,111,111 | 10,600,000 | -511,111 | $141.56M | $167.48M | 2.93% | +$25.92M |
| Merus N V | 3,000,000 | 3,155,555 | +155,555 | $126.27M | $165.98M | 2.91% | +$39.71M |
| Vera Therapeutics, Inc.(VERA) | 5,701,900 | 6,300,000 | +598,100 | $136.96M | $148.43M | 2.60% | +$11.47M |
| Amicus Therapeutics Inc. COM | 20,500,000 | 18,000,000 | -2,500,000 | $167.28M | $103.14M | 1.81% | -$64.14M |
| Alkermes plc(ALKS) | 2,450,000 | 2,900,000 | +450,000 | $80.90M | $82.97M | 1.45% | +$2.07M |
| Ocular Therapeutix, Inc.(OCUL) | 8,060,000 | 7,400,000 | -660,000 | $59.08M | $68.67M | 1.20% | +$9.59M |
| 89bio Inc | 6,350,000 | 6,750,000 | +400,000 | $46.16M | $66.28M | 1.16% | +$20.12M |
| Centessa Pharmaceuticals PlcADR | 4,050,000 | 5,000,000 | +950,000 | $58.24M | $65.70M | 1.15% | +$7.46M |
| uniQure N.V.(QURE) | 2,175,000 | 3,625,000 | +1,450,000 | $23.05M | $50.53M | 0.88% | +$27.48M |
| Taysha Gene Therapies, Inc.(TSHA) | 19,999,999 | 21,700,000 | +1,700,001 | $27.80M | $50.13M | 0.88% | +$22.33M |
| Blueprint Medicines Corp | 3,850,000 | 375,000 | -3,475,000 | $340.76M | $48.07M | 0.84% | -$292.70M |
| Tourmaline Bio Inc | 2,425,000 | 2,555,555 | +130,555 | $36.88M | $40.86M | 0.72% | +$3.98M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 8,700,000 | 4,500,000 | -4,200,000 | $65.25M | $40.32M | 0.71% | -$24.93M |
| MannKind Corporation(MNKD) | 8,750,000 | 5,850,000 | -2,900,000 | $44.01M | $21.88M | 0.38% | -$22.13M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 4,645,548 | 3,725,000 | -920,548 | $21.56M | $16.80M | 0.29% | -$4.76M |
| Septerna, Inc.(SEPN) | 1,337,500 | 1,237,500 | -100,000 | $7.74M | $13.08M | 0.23% | +$5.34M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 830,000 | 330,000 | -500,000 | $30.05M | $12.00M | 0.21% | -$18.06M |
| Whitehawk Therapeutics, Inc.(WHWK) | 2,849,402 | 2,849,402 | 0 | $5.07M | $5.33M | 0.09% | +$256.4K |
| Autolus Therapeutics plcADR(AUTL) | 9,910,642 | 0 | -9,910,642 | $15.36M | $0 | — | -$15.36M |
| Intra-Cellular Therapies Inc | 625,000 | 0 | -625,000 | $82.45M | $0 | — | -$82.45M |
| Sarepta Therapeutics, Inc.(SRPT) | 2,674,835 | 0 | -2,674,835 | $170.71M | $0 | — | -$170.71M |
| Vaxcyte, Inc.(PCVX) | 1,000,000 | 0 | -1,000,000 | $37.76M | $0 | — | -$37.76M |